G Fuhrer1, M J Gallimore, W Heller
1Kreiskrankenhaus Reutlingen, Federal Republic of Germany.
Plasma Factor XII (FXII), also known as Hageman factor, is crucial for defense systems like coagulation and fibrinolysis. Blocking FXII activation may offer therapeutic benefits in various clinical conditions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: